S. Muoio & Co’s Urovant Sciences Ltd. UROV Stock Holding History

S. Muoio & Co’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-47,401	Closed	-$765K	–	87
2020 Q4	$765K	Buy	+47,401	New	+$587K	0.83%	50

S. Muoio & Co's UROV Position: Q1 2021 in Review

S. Muoio & Co sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 47,401 shares — an estimated $765K sold.

S. Muoio & Co first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $765K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

S. Muoio & Co reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
S. Muoio & Co sold 47,401 Urovant Sciences Ltd. shares in Q1 2021, an estimated $765K.
S. Muoio & Co first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
S. Muoio & Co's Urovant Sciences Ltd. position peaked at $765K in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on S. Muoio & Co's 13F filing for Q1 2021, filed 14 May 2021.